Physician profile
Dorota M Malinowski
NPI 1194747253
$16,955.09
in general payments reported to CMS, 2019-2025
62 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,576 · 2020: $2,912 · 2021: $3,452 · 2022: $2,980 · 2023: $1,972 · 2024: $1,794 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,035.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,676.73 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $2,123.13 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $939.47 | 2019-2024 | Jardiance, Mounjaro, Zepbound |
| Mannkind Corporation | $880.64 | 2019-2023 | Afrezza |
| Dexcom, INC. | $791.35 | 2019-2024 | Dexcom G6 Transmitter |
| Amgen INC. | $711.29 | 2019-2024 | Prolia, Evenity, Repatha |
| Insulet Corporation | $645.73 | 2019-2024 | Omnipod |
| Abbott Laboratories | $620.04 | 2019-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $594.94 | 2019-2024 | |
| Antares Pharma, INC. | $574.24 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Sanofi-Aventis U.S. LLC | $524.92 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $513.41 | 2019-2024 | Synjardy, Jardiance, Tradjenta |
| Cequr Corporation | $499.51 | 2022-2025 | Cequr Simplicity |
| Amarin Pharma, INC. | $371.33 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $334.53 | 2021-2024 |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorota Malinowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.